Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer

Anticancer Research

Volumn 20, Issue 6 C, 2000, Pages 4665-4672

  Focan, C ^a   Bury, J ^a   Beauduin, M ^a   Herman, M L ^a   Vindevoghel, A ^a   Lecomte, M ^a   Brohee D ^a   Canon, J L ^a   Focan Henrard, D ^a  

^a Clinique Saint Joseph   (Belgium)

Author keywords

5 fluorouracil; Chemotherapy; Colorectal cancer

Indexed keywords

FLUOROURACIL; LEVAMISOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PORTAL VEIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; LEUCOVORIN; LEVAMISOLE; MALE; MIDDLE AGED; NEOPLASM STAGING; PORTAL SYSTEM; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 0034495693     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Adjuvant therapy of colorectal cancer: Why we still don't known
2. Comparative efficacy of adjuvant chemotherapy in patients with Dukes B versus Dukes C colon cancer: Results from four national Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)
3. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
4. Adjuvant therapy of colon cancer
5. Colorectal carcinoma: A survey of 1345 cases 1950-1984
6. Cancer of the colon
7. Colorectal cancer
8. Cancer of the rectum
9. Adjuvant therapy for patients with colon and rectal cancer
10. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
11. The prophylatic treatment of cancer at the time of operation
12. Effect of surgical removal on the growth and kinetics of residual tumor
13. A randomised controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer
14. Tolérance d'un traitement adjuvant associant une chimiothérapie intraportale post-opératoire et un traitement systémique á base de 5-flourouracil dans les carcinomes colorectaux de stades histopronostiques défavorables
15. Adjuvant intraportal chemotherapy for Dukes B2 and C colorectal cancer receiving also systemic treatment. Results of a multicentre randomised trial
16. The classification of cancer of the rectum
17. Randomized trial of adjuvant perioperative chemotherapy in radically resected colorectal cancer (SAKK 40/87)
18. Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer
19. Introduction of cumulative dose intensity product (DIP) for measuring the delivered dose intensity (DI) of chemotherapy - Analysis of the British Columbia Breast Cancer Randomized Study
20. Non parametric estimation from incomplete observations
21. Regression models and life-tables
22. Levamisole adds granulocyte toxicity to 5 FU-based chemotherapies in adjuvant treatment of Dukes B-C colorectal cancer. A preliminary report
23. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
24. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project protocol C-03
25. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer
26. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin and levamisole in patients with Dukes'B and C carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project C-04
27. Fluorouracil (FU) leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer: 5 Year final report of Int-0089
28. Controlled trial of fiuorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer
29. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer
30. Adjuvant systemic treatment of colorectal cancer: Duration of therapy
31. A randomized trial of adjuvant therapy of stage III colon cancer: Levamisole and 5-fluorouracil versus 5-fluorouracil alone
32. The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer
33. Multicentre randomized trial of protracted venous infusion (PVI) 5 FU compared to 5 FU/folinic acid (5 FU/FA) as adjuvant therapy for colorectal cancer
34. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: A Southwest Oncology Group Study
35. Does biomodulation of 5-fluorouracil improve results?